Point72 Asset Management L.P. bought a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 209,900 shares of the medical instruments supplier’s stock, valued at approximately $8,889,000. Point72 Asset Management L.P. owned 0.42% of Merit Medical Systems as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Advisors Asset Management Inc. raised its holdings in Merit Medical Systems by 28.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock worth $142,000 after purchasing an additional 820 shares during the period. Ameritas Investment Partners Inc. raised its holdings in Merit Medical Systems by 20.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after purchasing an additional 738 shares during the period. SG Americas Securities LLC bought a new position in Merit Medical Systems in the 3rd quarter worth $189,000. Riverhead Capital Management LLC raised its holdings in Merit Medical Systems by 67.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock worth $198,000 after purchasing an additional 2,098 shares during the period. Finally, Flinton Capital Management LLC raised its holdings in Merit Medical Systems by 67.4% in the 2nd quarter. Flinton Capital Management LLC now owns 5,236 shares of the medical instruments supplier’s stock worth $200,000 after purchasing an additional 2,108 shares during the period. 90.89% of the stock is currently owned by institutional investors.

MMSI has been the topic of a number of recent research reports. UBS cut Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a report on Monday, August 28th. Citigroup cut Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price target on the stock. in a report on Monday, August 28th. They noted that the move was a valuation call. Raymond James Financial reissued an “outperform” rating and set a $44.00 price target on shares of Merit Medical Systems in a report on Monday, August 28th. Canaccord Genuity reissued a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a report on Wednesday, September 6th. Finally, Zacks Investment Research cut Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $43.77.

Shares of Merit Medical Systems, Inc. (NASDAQ MMSI) opened at $44.90 on Friday. The company has a current ratio of 2.78, a quick ratio of 1.43 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $2,178.63, a PE ratio of 34.17, a price-to-earnings-growth ratio of 2.94 and a beta of 1.23. Merit Medical Systems, Inc. has a twelve month low of $24.23 and a twelve month high of $45.50.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.02. The business had revenue of $179.30 million for the quarter, compared to analysts’ expectations of $181.28 million. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The business’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period last year, the firm earned $0.26 earnings per share. equities research analysts predict that Merit Medical Systems, Inc. will post 1.27 EPS for the current year.

In other news, Director Kent W. Stanger sold 2,918 shares of the firm’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $44.55, for a total transaction of $129,996.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 5.00% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Point72 Asset Management L.P. Buys Shares of 209,900 Merit Medical Systems, Inc. (MMSI)” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at https://www.watchlistnews.com/point72-asset-management-l-p-buys-shares-of-209900-merit-medical-systems-inc-mmsi/1769064.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.